Skip to Main Content
Samer Al Hadidi, M.D.

Samer Al Hadidi, M.D.

Titles and Appointments

Clinical Director, Amyloidosis Program

Associate Professor

School
Medical School
Department
Internal Medicine

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Samer Al Hadidi, M.D., M.S., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He specializes in plasma cell disorders, including multiple myeloma and light chain amyloidosis, and cellular therapies, including CAR T-cell therapy and hematopoietic stem cell transplantation.

    Originally from Jordan, Dr. Al Hadidi earned his medical degree with highest honors at the University of Jordan School of Medicine. He completed a residency in internal medicine at Hurley Medical Center/Michigan State University. He received advanced training through a hematology and oncology fellowship at Baylor College of Medicine in Houston. He also holds a master’s degree in clinical research and statistical analysis from the University of Michigan in Ann Arbor, which he received with highest honors.

    Prior to joining the UT Southwestern faculty in 2025, Dr. Al Hadidi was on the faculty at the University of Arkansas for Medical Sciences in Little Rock and at Michigan State University in Flint.

    Dr. Al Hadidi serves as Clinical Director of the Amyloidosis Program and Leader of the Fellows’ Plasma Cell Disorders Clinic. He is nationally recognized as an expert in treating multiple myeloma and utilizing cellular therapies for plasma cell disorders.

    A Fellow of the American College of Physicians, he is also a member of numerous professional organizations, including the American Society of Hematology, the American Society for Transplantation and Cellular Therapy, and the American Society of Clinical Oncology. Dr. Al Hadidi serves on the Hematology Specialty Board of the American Board of Internal Medicine, helping to oversee certification standards, specialty assessment, and governance policies for hematology.

    Dr. Al Hadidi has delivered national and international presentations and published more than 125 peer-reviewed academic articles related to his areas of expertise.

    In 2025, he received the Fellows Appreciation Award for Clinical Teaching from the University of Arkansas for Medical Sciences.

    Personal Note

    When he’s not at work, Dr. Al Hadidi enjoys traveling and spending time with his family.

  • Education
    Medical School
    University of Jordan Faculty of Medicine, Jordan (2011)
    Residency
    Hurley Medical Center - Michigan State University (2016), Internal Medicine
    Graduate School
    University of Michigan School of Public Health (2017)
    Fellowship
    Baylor College of Medicine (2021), Hematology Oncology
  • Research Interest
    • CAR-T Therapy
    • Drug Development
    • Immunotherapy
  • Honors & Awards
    • Fellows Appreciation Award for Clinical Teaching
      University of Arkansas for Medical Sciences (2025)
    • Exemplary Abstract Award
      International Myeloma Society (2023)
    • Helio Disruptive Innovators Award
      American Society of Clinical Oncology (2023)
    • Fellow of the Year, Center of Cell and Gene Therapy
      Baylor College of Medicine (2021)
    • Fellow of the Year, Gastrointestinal Oncology
      Baylor College of Medicine (2021)
    • Conquer Cancer Merit Award
      American Society of Clinical Oncology (2020)
  • Professional Associations/Affiliations
    • American Association for Cancer Research
    • American College of Physicians
    • American Society for Transplantation and Cellular Therapy
    • American Society of Clinical Oncology
    • American Society of Hematology
    • International Myeloma Society
    • International Myeloma Working Group
    • Southwest Oncology Group
    • Texas Society of Clinical Oncology